TUM – Technical University of Munich Menu
Deutsches Herzzentrum der TU München - Foto: DHM / TUM
Deutsches Herzzentrum der TU München - Foto: DHM / TUM
  • Research news

Shutting down a gene may reduce heart attack risk

Mutated gene safeguards against heart attacks

People with a specific gene mutation have a 50 percent lower risk of suffering a heart attack. This is what an international team of researchers headed by the cardiologist Prof. Heribert Schunkert, medical director of the German Heart Center at the Technical University of Munich (TUM), discovered in a broad comparative study. If this gene were switched off with medications it could reduce the risk of coronary disease significantly.

An international research group headed by the cardiologist Prof. Heribert Schunkert, medical director of the German Heart Center at TU Munich, has discovered a gene mutation that may significantly reduce the probability of suffering a heart attack. “This discovery makes it considerably easier to develop new medications that simulate the effect of this mutation,” explains Prof. Schunkert. “This gives follow-on research aiming at reducing heart attacks in the future a concrete goal.”

Fighting heart attacks with big data

For the large-scale study at hand, the scientists analyzed 13,000 different genes from a pool of 200,000 participants – both heart attack patients and healthy control persons. They were on the lookout for correlations between gene mutations and coronary artery disease.

For a number of genes, the researchers registered a correlation, including the ANGPTL4 (angiopoietin-like 4) gene. In addition, subjects with the mutated ANGPTL4 gene had significantly lower triglyceride values in their blood.

“The blood fat triglyceride serves as an energy store for the body. However, as with LDL cholesterol, elevated values lead to an increased risk of cardiovascular disease. Low values, by contrast, lower the risk,” explains Prof. Jeanette Erdmann, director of the Institute of Integrative and Experimental Genomics at the University of Lübeck, who also collaborated on the work.

Importance of triglycerides underestimated

According to professor Schunkert the significance of triglycerides for human health hitherto has been underestimated: “For most patients the focus still lies on cholesterol. A differentiation is always made between the healthy HDL and the harmful LDL cholesterol variants. However, in the mean time we know that the HDL values always run inversely proportional to those of the triglycerides and that HDL itself actually tends to behave in a neutral manner.”

“The triglycerides, on the other hand, are the second important blood fat, alongside the harmful LDL cholesterol. We published this in the Lancet two years ago,” explains Prof. Schunkert. “The only reason HDL blood values are still measured is because, together with HDL and triglyceride values, they can be used to derive the LDL values, which cannot be measured directly.”

The current study now shows that the concentration of triglycerides in the blood are influenced not only by nutrition and predisposition, but also by the ANGPTL4 gene. “At the core of our data is the lipoprotein lipase (LPL) enzyme. It causes the decomposition of triglycerides in the blood,” explains Prof. Erdmann

Normally, ANGPTL4 hems the LPL enzyme, causing blood fat values to rise. The mutations identified by the researchers disable the function of this gene and thereby ensure that the triglyceride value drops significantly.

New approach to fighting coronary disease

“At the same time,” says Jeanette Erdmann, “we discovered that the body does not even need the ANGPTL4 gene and manages wonderfully without it. It seems to be superfluous.” Shutting down the gene or inhibiting the LPL enzyme in another manner may ultimately protect against coronary disease.

“Based on our results, medications now need to be developed that neutralize the effect of the ANGPTL4 gene, thereby reducing the risk of a heart attack,” says the study leader, Prof. Schuinkert. “Other researchers have already done this successfully in animal tests. They drastically reduced the blood fat levels in monkeys that received a neutralizing antibody against ANGPTL4. This feeds the hope that antibody preparations with a similar effect can soon be used successfully in humans.”

129 scientists from 15 countries collaborated on the four-year study. The researchers present their results in the latest issue of the New England Journal of Medicine. The work was funded, among others, by the National Institutes of Health (NIH) in USA, the European Research Council (ERC) and the German Research Foundation (DFG), as well as the German Federal Ministry of Education and Research (BMBF).

Publication:

N. Stitziel, ...., H. Schunkert; Coding Variation in ANGPTL4, LPL, and SVEP1 and Risk of Coronary Disease; New England Journal of Medicine, March 3, 2016 – DOI: 10.1056/NEJMoa1507652

Contact:

For further information please contact Ms Helga Korn, German Heart Center in Munich, Phone: +49 89 1218 1701 - E-mail. Please direct requests for interviews with Prof. Heribert Schunkert to Ms Siebe, Phone: +49 89 1218 4073.

Corporate Communications Center

Technical University of Munich

Article at tum.de

Angstgestörte Patienten kommen in einer akuten Herzinfarkt-Situation früher in die Notaufnahmen. Die Diagnose mittels eines Elektrogardiogramms (EKG, s. Bild) und eine medikamentöse Therapie können dann schneller stattfinden, was die Überlebenschance verbessert. (Bild: johan63 / istockphoto)

Anxiety as a protective factor after a heart attack

Fear protects people from danger. A team from the Technical University of Munich (TUM) and Helmholtz Zentrum München has discovered that this applies even to pathological anxiety disor-ders. Patients who generally suffer...

Computergrafik eines Herzmuskels.

Heart attacks: The dangerous first year

Heart attacks pose a greater threat to women than to men. A team at the Technical University of Munich (TUM) has determined that in the first year after a heart attack women are subject to a significantly higher mortality...

Dr. Markus Krane operiert am Deutschen Herzzentrum München mit der Ozaki-Methode. (Bild: A. Heddergott / TUM)

A template for a new heart valve

A new method allows surgeons to reconstruct entire heart valves from the patient’s own tissue. This surgical procedure is currently only used at a handful of centres in the world. Recently, PD Dr. Markus Krane, Deputy...

Ein Bild eines menschliches Skelett mit künstlichen Halsschlagadern.

microRNA may reduce stroke risk

The molecule microRNA-210 stabilises deposits in the carotid artery and can prevent them from tearing. Thus, it may prevent dangerous blood clots from forming. This is what scientists headed by Prof. Lars Mägdefessel,...

Aufnahme der Blutgefäße auf einem Herzmuskel.

Vanishing capillaries

Diabetics have a significantly higher risk of suffering a heart attack. A research team at the Technical University of Munich (TUM) has now identified one of the causes: Diabetes is associated with the loss of small blood...

Prof. Franz Pfeiffer und PD Dr. Daniela Münzel am Mini-Synchrotron Munich Compact Light Source.

Miniature particle accelerator saves on contrast agents

The most prevalent method for obtaining images of clogged coronary vessels is coronary angiography. For some patients, however, the contrast agents used in this process can cause health problems. A team at the Technical...

Ein Mann sitzt auf einer Bank und stützt den Kopf auf die Arme.

Depressive disorder is hard on the heart

Depression poses a risk for cardiovascular diseases in men that is just as great as that posed by high cholesterol levels and obesity. Researchers from the Technical University of Munich (TUM), the Helmholtz Zentrum München...

Im Labor gezüchtete Herzzellen werden mithilfe von Quallenproteinen zum Leuchten gebracht. (Foto: Alessandra Moretti /TUM)

Luminous heart cells

Cell models from stem cells serve an ever-increasing role in research of cardiac dysfunction. Researchers at the Technical University of Munich (TUM) have succeeded in producing cells which offer new insights into...

Computergrafik eines menschlichen Körpers mit hervorgehobenem Herz

Telling irregularities

The heart rate may be an indicator of a person’s life expectancy. A research team at the Technical University of Munich (TUM) has to this end analyzed an effect which at first seems paradoxical: Minor irregularities in the...

Intelligente Zahnschiene SensoBite - Bild: Bernhard Schmidt / TUM

A look at the digital medicine of the future

In the future, there may be medication that is tailored individually to each patient. Doctors might operate wearing 3D data glasses and thus be able to work with greater precision. Diagnosing rare diseases, which today can...

Spitzenmedizin in der Lazarettstraße: Seit 40 Jahren werden Patienten im Deutschen Herzzentrum München behandelt. (Foto: Deutsches Herzzentrum München)

40 Years of the German Heart Centre Munich

Germany’s first successful heart transplant was carried out in 1981, right in the middle of Munich at the German Heart Centre of the Technische Universität München (TUM). At an anniversary event to be held on Wednesday...